Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Current Opinion in Hematology
|
January 23, 1999
CD5 B cells and B-cell malignancies
P M Lydyard, A P Jewell, C Jamin, et al.
British Journal of Biomedical Science
|
July 7, 2005
Hepatitis C antibodies in asymptomatic first-time blood donors in The Gambia: prevalence and risk factors
C I Mboto, A Davies-Russell, M Fielder, et al.
African Health Sciences
|
July 1, 2010
CD4+ lymphocyte values and trends in individuals infected with human immunodeficiency virus and/or co-infected with hepatitis C virus in the Gambia
C I Mboto, A Davies-Russell, M Fielder, et al.
West African Journal of Medicine
|
August 11, 2009
Prevalence of HIV-1, HIV-2, hepatitis C and co-infection in The Gambia
C I Mboto, M Fielder, A Davies-Russell, et al.
British Journal of Biomedical Science
|
October 27, 2010
Hepatitis C virus prevalence and serotypes associated with HIV in The Gambia
C I Mboto, M Fielder, A Davies-Russell, et al.
Leukemia Research
|
January 1, 1991
Cellular cytotoxic function and potential in acute myelogenous leukaemia
S H Lim, C P Worman, A P Jewell, et al.
Acta Haematologica
|
January 1, 1991
Recombinant alpha-interferons, thyroid irradiation and thyroid disease
F J Giles, C P Worman, A P Jewell, et al.
Leukemia & Lymphoma
|
January 1, 1997
Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy
A P Jewell, C P Worman, F J Giles, et al.
Leukemia & Lymphoma
|
June 1, 1995
Growth factors can protect B-chronic lymphocytic leukaemia cells against programmed cell death without stimulating proliferation
A P Jewell, P M Lydyard, C P Worman, et al.
Leukemia & Lymphoma
|
August 1, 1992
Resistance of chronic lymphocytic leukaemia cells to interferon-alpha generated lymphokine activated killer cells
A P Jewell, C P Worman, F J Giles, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Current Opinion in Hematology
|
January 23, 1999
CD5 B cells and B-cell malignancies
P M Lydyard, A P Jewell, C Jamin, et al.
British Journal of Biomedical Science
|
July 7, 2005
Hepatitis C antibodies in asymptomatic first-time blood donors in The Gambia: prevalence and risk factors
C I Mboto, A Davies-Russell, M Fielder, et al.
African Health Sciences
|
July 1, 2010
CD4+ lymphocyte values and trends in individuals infected with human immunodeficiency virus and/or co-infected with hepatitis C virus in the Gambia
C I Mboto, A Davies-Russell, M Fielder, et al.
West African Journal of Medicine
|
August 11, 2009
Prevalence of HIV-1, HIV-2, hepatitis C and co-infection in The Gambia
C I Mboto, M Fielder, A Davies-Russell, et al.
British Journal of Biomedical Science
|
October 27, 2010
Hepatitis C virus prevalence and serotypes associated with HIV in The Gambia
C I Mboto, M Fielder, A Davies-Russell, et al.
Leukemia Research
|
January 1, 1991
Cellular cytotoxic function and potential in acute myelogenous leukaemia
S H Lim, C P Worman, A P Jewell, et al.
Acta Haematologica
|
January 1, 1991
Recombinant alpha-interferons, thyroid irradiation and thyroid disease
F J Giles, C P Worman, A P Jewell, et al.
Leukemia & Lymphoma
|
January 1, 1997
Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy
A P Jewell, C P Worman, F J Giles, et al.
Leukemia & Lymphoma
|
June 1, 1995
Growth factors can protect B-chronic lymphocytic leukaemia cells against programmed cell death without stimulating proliferation
A P Jewell, P M Lydyard, C P Worman, et al.
Leukemia & Lymphoma
|
August 1, 1992
Resistance of chronic lymphocytic leukaemia cells to interferon-alpha generated lymphokine activated killer cells
A P Jewell, C P Worman, F J Giles, et al.
Page
of 3